JPRN-UMIN000012428已完成2 期
A feasibility study of Anthracycline-based regimen followed by Nab-Paclitaxel as adjuvant chemotherapy for breast cancer.(SBCCSG-32) - A feasibility study of Anthracycline-based regimen followed by Nab-Paclitaxel as adjuvant chemotherapy for breast cancer.(SBCCSG-32)
Saitama Breast Cancer Clinical Study Group(SBCCSG)0 个研究点目标入组 40 人开始时间: 2013年12月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) HER2 is positive by surgical specimen. 2) Pregnant or lactation women. 3) History of other malignancies within the last 5 years. 4) History of bilateral breast cancer 5) History of serious allergy 6) Patients judged by the investigator to be unfit to be enrolled into the study.
研究者
相似试验
招募中
1 期
Feasibility study of Anthracycline Based Regimen followed by Nab-Paclitaxel as adjuvant chemotherapy for elderly patients with breast cancerBreast cancerJPRN-UMIN000009267Shimane University Hospital20
已完成
2 期
A feasibility study of sequential Anthracycline-based regimen and Nab-Paclitaxel / Trastuzumab followed by Trastuzumab as postoperative adjuvant chemotherapy for Her2 positive breast cancer.(SBCCSG-22)Primary breast cancerJPRN-UMIN000006085Saitama Breast Cancer Clinical Study Group(SBCCSG)30
尚未招募
不适用
Cardio-oncology studyPACTR20180400321843950
已完成
3 期
Randomized study of anthracycline vs. TS-1 in patients with metastatic or recurrent breast cancerMetastatic or recurrent breast cancerJPRN-UMIN000005449SELECT BC-CONFIRM executive committee200
已完成
不适用
Randomised Comparison of Cyclical Anthracycline-Based Chemotherapy [PA(BI)OE] with Alternating Chemotherapy [ChlVPP/PABIOE] in Advanced Hodgkin's Diseaseymphoma (Hodgkin's)Lymphoma (Hodgkin's)CancerISRCTN46778796British National Lymphoma Investigation (BNLI) (UK)